Multilocus Variable-number Tandem-repeat Analysis-confirmed Emergence of a Macrolide Resistance-associated Mutation in Mycoplasma Pneumoniae During Macrolide Therapy for Interstitial Pneumonia in an Immunocompromised Child

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 2012 Jul 21

PMID 22814468

Citations 6

Authors

Sebastien Hantz

Fabien Garnier

Olivia Peuchant

Celine Menetrey

Alain Charron

Marie-Cecile Ploy

Cecile Bebear

Sabine Pereyre

Affiliations

Soon will be listed here.

Abstract

A child with Job's syndrome was treated for pneumonia due to Mycoplasma pneumoniae. A mixed population of wild-type bacteria and an A2059G mutant was detected during josamycin treatment failure. The same multilocus variable-number tandem-repeat analysis (MLVA) type (MLVA type I) was isolated before and after treatment failure. The child recovered after ciprofloxacin treatment.

Citing Articles

Infections and Primary Immune Deficiencies.

Poddighe D, Demirkaya E, Sazonov V, Romano M Int J Clin Pract. 2022; 2022:6343818.

PMID: 35855053 PMC: 9286979. DOI: 10.1155/2022/6343818.

Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program.

Waites K, Ratliff A, Crabb D, Xiao L, Qin X, Selvarangan R J Clin Microbiol. 2019; 57(11).

PMID: 31484701 PMC: 6813023. DOI: 10.1128/JCM.00968-19.

: A Potentially Severe Infection.

Bajantri B, Venkatram S, Diaz-Fuentes G J Clin Med Res. 2018; 10(7):535-544.

PMID: 29904437 PMC: 5997415. DOI: 10.14740/jocmr3421w.

Mechanism of resistance acquisition and treatment of macrolide-resistant pneumonia in children.

Yang H, Song D, Shim J Korean J Pediatr. 2017; 60(6):167-174.

PMID: 28690643 PMC: 5500384. DOI: 10.3345/kjp.2017.60.6.167.

Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Waites K, Xiao L, Liu Y, Balish M, Atkinson T Clin Microbiol Rev. 2017; 30(3):747-809.

PMID: 28539503 PMC: 5475226. DOI: 10.1128/CMR.00114-16.

References

Grimbacher B, Holland S, Puck J . Hyper-IgE syndromes. Immunol Rev. 2005; 203:244-50. DOI: 10.1111/j.0105-2896.2005.00228.x. View

Lenglet A, Herrador Z, Magiorakos A, Leitmeyer K, Coulombier D . Surveillance status and recent data for Mycoplasma pneumoniae infections in the European Union and European Economic Area, January 2012. Euro Surveill. 2012; 17(5). DOI: 10.2807/ese.17.05.20075-en. View

Chironna M, Sallustio A, Esposito S, Perulli M, Chinellato I, di Bari C . Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children. J Antimicrob Chemother. 2011; 66(4):734-7. DOI: 10.1093/jac/dkr003. View

Spuesens E, Meijer A, Bierschenk D, Hoogenboezem T, Donker G, Hartwig N . Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The Netherlands. J Clin Microbiol. 2012; 50(6):1999-2004. PMC: 3372106. DOI: 10.1128/JCM.00400-12. View

Averbuch D, Hidalgo-Grass C, Moses A, Engelhard D, Nir-Paz R . Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010. Emerg Infect Dis. 2011; 17(6):1079-82. PMC: 3358208. DOI: 10.3201/eid/1706.101558. View

Pereyre S, Charron A, Hidalgo-Grass C, Touati A, Moses A, Nir-Paz R . The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel. PLoS One. 2012; 7(6):e38585. PMC: 3368914. DOI: 10.1371/journal.pone.0038585. View

Cardinale F, Chironna M, Dumke R, Binetti A, Daleno C, Sallustio A . Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia. Eur Respir J. 2011; 37(6):1522-4. DOI: 10.1183/09031936.00172510. View

Pereyre S, Charron A, Renaudin H, Bebear C, Bebear C . First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. J Clin Microbiol. 2007; 45(11):3534-9. PMC: 2168523. DOI: 10.1128/JCM.01345-07. View

Pereyre S, Guyot C, Renaudin H, Charron A, Bebear C, Bebear C . In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. Antimicrob Agents Chemother. 2004; 48(2):460-5. PMC: 321523. DOI: 10.1128/AAC.48.2.460-465.2004. View

10.

Atkinson T, Balish M, Waites K . Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008; 32(6):956-73. DOI: 10.1111/j.1574-6976.2008.00129.x. View

11.

Waites K, Talkington D . Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004; 17(4):697-728, table of contents. PMC: 523564. DOI: 10.1128/CMR.17.4.697-728.2004. View

12.

Degrange S, Cazanave C, Charron A, Renaudin H, Bebear C, Bebear C . Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae. J Clin Microbiol. 2009; 47(4):914-23. PMC: 2668363. DOI: 10.1128/JCM.01935-08. View

13.

Techasaensiri C, Tagliabue C, Cagle M, Iranpour P, Katz K, Kannan T . Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains. Am J Respir Crit Care Med. 2010; 182(6):797-804. PMC: 2949405. DOI: 10.1164/rccm.201001-0080OC. View

14.

Wolff B, Thacker W, Schwartz S, Winchell J . Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob Agents Chemother. 2008; 52(10):3542-9. PMC: 2565909. DOI: 10.1128/AAC.00582-08. View

15.

Dumke R, von Baum H, Luck P, Jacobs E . Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect. 2009; 16(6):613-6. DOI: 10.1111/j.1469-0691.2009.02968.x. View

16.

Peuchant O, Menard A, Renaudin H, Morozumi M, Ubukata K, Bebear C . Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother. 2009; 64(1):52-8. DOI: 10.1093/jac/dkp160. View

17.

Yamada M, Buller R, Bledsoe S, Storch G . Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States. Pediatr Infect Dis J. 2012; 31(4):409-0. DOI: 10.1097/INF.0b013e318247f3e0. View

18.

Dumke R, Luck P, Noppen C, Schaefer C, von Baum H, Marre R . Culture-independent molecular subtyping of Mycoplasma pneumoniae in clinical samples. J Clin Microbiol. 2006; 44(7):2567-70. PMC: 1489489. DOI: 10.1128/JCM.00495-06. View

19.

Morozumi M, Iwata S, Hasegawa K, Chiba N, Takayanagi R, Matsubara K . Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob Agents Chemother. 2007; 52(1):348-50. PMC: 2223908. DOI: 10.1128/AAC.00779-07. View

20.

Bebear C, Pereyre S, Peuchant O . Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. Future Microbiol. 2011; 6(4):423-31. DOI: 10.2217/fmb.11.18. View